Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway
Aims: To investigate the potential protective role of montelukast (Mont) in the pre-eclampsia rat model induced by L-NG-Nitro arginine methyl ester (L-NAME). Methods and materials: Thirty-two pregnant female albino Wistar rats were assigned to four groups: the control group: pregnant rats received v...
Main Authors: | Walaa Yehia Abdelzaher, Gomaa Mostafa-Hedeab, Haitham Ahmed Bahaa, Ahmad Mahran, Michael Atef Fawzy, Sara Mohamed Naguib Abdel Hafez, Nermeen N. Welson, Remon Roshdy Rofaeil |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/8/914 |
Similar Items
-
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
by: Ludwig Aigner, et al.
Published: (2020-12-01) -
Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
by: Cátia F. Marques, et al.
Published: (2022-08-01) -
Effect of montelukast on leukotriene B4 metabolism in asthma
by: HU Yu, et al.
Published: (2023-05-01) -
Non-obvious effects of montelukast – leukotriene receptor blocker: frigoprotective and anticonvulsant properties
by: S.Yu. Shtrygol, et al.
Published: (2021-06-01) -
Dipeptidyl peptidase-4 inhibitor: Sitagliptin down-regulated toll-like receptor 4 signaling pathway to reduce uterine injury in rats
by: Remon Rofaeil, et al.
Published: (2022-11-01)